Press "Enter" to skip to content

Lilly eyes more cancer deals, but wary of CAR-T, gene therapy

Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology this week, but it plans to remain on the sidelines when it comes to two of the hottest areas of drug development.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/gspib-UGIA0/lilly-eyes-more-cancer-deals-but-wary-of-car-t-gene-therapy-idINKCN1P5294

Also Read:   Soluble fiber may improve diabetes control